Linda Palczuk - 24 Jan 2025 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, as attorney-in-fact
Issuer symbol
AVDL
Transactions as of
24 Jan 2025
Net transactions value
$0
Form type
4
Filing time
28 Jan 2025, 16:22:54 UTC
Previous filing
22 Jan 2025
Next filing
31 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVDL Stock Option (Right to Buy) Gift $0 -25,000 -100% $0.000000 0 24 Jan 2025 Ordinary Shares 25,000 $10.93 Direct F1
holding AVDL Stock Option (Right to Buy) 25,000 24 Jan 2025 Ordinary Shares 25,000 $10.93 By Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options become exercisable in three equal annual installments on each of the first three anniversaries following the 12/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date.
F2 On January 24, 2025, the Reporting Person transferred 25,000 options to a revocable trust of which the Reporting Person is trustee.